Mental Health Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tokyo Medical and Dental University
L-[methyl-C-11] methionine-positron emission tomography used to monitor treatment of glioma
December 17th, 2005
L-[methyl-C-11] methionine (MET)-positron emission tomography (PET) could be used to monitor the treatment of glioma. According to recent research published in the Journal of Neurosurgery, "The authors retrospectively analyzed the data obtained in patients who had undergone MET-PET studies to clarify the relationship between MET uptake and tumor biological features and to discuss the clinical usefulness of MET-PET studies." "One hundred ninety-four patients with cerebral glioma or suspected glioma underwent PET scanning 20 minutes after injection of MET, whose uptake into the tumor was expressed as a ratio to contralateral healthy brain tissue...
Source: Mental Health Law Weekly (2005-12-17)
|
